MedPath
NMPA Approval

Montmorillonite Suspension

国药准字H20060834

January 29, 2021

国药准字H20060834

Drug Information

蒙脱石混悬液

立榭

白敬宇

口服混悬剂

90ml:9g

化学药品

January 29, 2021

Company Information

Applicant Company

南京经济技术开发区惠中路1号

Manufacturing Company

南京经济技术开发区惠中路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

蒙脱石混悬液 - NMPA 批准文号 | MedPath